NCT06061497

Brief Summary

Introduction Asthma is a chronic inflammatory disease of the respiratory airways and is considered a Public Health problem, which lacks a personalized multidisciplinary intervention, to allow the user to develop mastery in the self-management of his disease. The project intends to answer the question: What methods could be used to enhance the use of asthma controller therapy? Methods Randomized and controlled clinical trial. The sample consists of users with asthma at Family Health Units in the municipality of Oliveira de Azeméis. There will be an experimental group that will undergo structured rehabilitation nursing consultations, and a control group that will receive the usual nursing care appropriate for asthma management. Both groups will be subject to two evaluation moments with the CARAT test and the AQLQ-M questionnaire. Results The aim is to evaluate the effectiveness of interventions for people with asthma implemented within the framework of a structured rehabilitation nursing consultation. The investigators expected to observe a clinically significant improvement with regard to disease control, quality of life, and user empowerment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable asthma

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable asthma

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 3, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 9, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

September 29, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2024

Completed
Last Updated

August 30, 2024

Status Verified

August 1, 2024

Enrollment Period

9 months

First QC Date

September 9, 2023

Last Update Submit

August 28, 2024

Conditions

Keywords

AsthmaNurseRehabilitationQuality of lifeBreathing exercisesClinical TrialsObstructive airway diseaseNon-pharmacological therapy

Outcome Measures

Primary Outcomes (3)

  • Symptom Control using the scale Allergic Rhinitis and Control of Asthma Test CARAT

    The CARAT questionnaire is composed of 10 questions that address upper and lower airway symptoms, sleep interference, activity limitation, and the need to increase medication over a four-week period. Scores above 24 indicate good disease control. Upper airway score (item 1-4): 0 Controlled if score \>8 Lower airway score (item 5-10): 0 Controlled if score ≥16

    At the first and last consultation in 4 weeks

  • Quality of life in asthma patients using the scale Mini Ashma Quality of Life Questionnaire (Mini- AQLQ)

    This instrument has 15 questions in the same domains as the original AQLQ (symptoms, activities, emotions and environment) and takes 3-4 minutes to complete. An increase of 0.5 in the Mini-AQLQ score is considered a clinically significant improvement.

    At the first and last consultation in 4 weeks

  • Measure patient enablement in asthma using the scale mPEI

    The mPEI is a six-item questionnaire. Each item is scored in a Likert-type scale from 0 ('same or less' or 'not applicable') to 2 ('much better'). There is a minimum score of 0 and a maximum score of 12. A higher score reflects higher patient enablement

    At the last consultation, an average of 4 weeks after the first consultation

Study Arms (2)

Abdomino-diaphragmatic breathing

EXPERIMENTAL

There are four consultations with autonomous rehabilitation nursing intervention: abdomino-diaphragmatic breathing. In addition to adding the health care that is recommended in the Integrated Care Process for Asthma in Children and Adults, of the Portuguese Directorate-General for Health, namely: Health education: Inhalation technique Adherence to treatment; Presence of comorbidities; Smoking; Other environmental factors; Promotion of physical activity.

Other: Abdomino-diaphragmatic breathingBehavioral: Usual Care

Usual care

PLACEBO COMPARATOR

They will have the care recommended in the Integrated Care Process for Asthma in Children and Adults, of the Portuguese Directorate-General for Health, namely: Health education: Inhalation technique Adherence to treatment; Presence of comorbidities; Smoking; Other environmental factors; Promotion of physical activity.

Behavioral: Usual Care

Interventions

Breathing should be done twice a day for 10 minutes.

Abdomino-diaphragmatic breathing
Usual CareBEHAVIORAL

Health education Review of inhaler technique Check adherence to treatment; Presence of comorbidities; Smoking; Other environmental factors; Promotion of physical activity

Abdomino-diaphragmatic breathingUsual care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of asthma, with R96 coding according to ICPC2;
  • Users enrolled in health units in the municipality of Oliveira de Azeméis.

You may not qualify if:

  • Impossibility of contacting the user to schedule the appointment;
  • Users with severe cognitive dysfunction or psychiatric illness with interference in memory and adherence;
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ACES Entre Douro e Vouga II- Aveiro Norte

Oliveira de Azeméis, Aveiro District, 3720-287, Portugal

Location

MeSH Terms

Conditions

AsthmaMouth BreathingLung Diseases, Obstructive

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Andreia Santos

    ACES Entre Douro e Vouga II

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

September 9, 2023

First Posted

September 29, 2023

Study Start

July 3, 2023

Primary Completion

March 30, 2024

Study Completion

March 30, 2024

Last Updated

August 30, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations